1、计划生育市场报告2022年12月CONTENTS2021年计划生育态势3供应商发货分析4全球采购方支出分析15与主要利益相关者讨论的要点18GLOBALMARKETSVISIBILITYPROJECTACKNOWLEDGEMENTS19APPENDICES21ACKNOWLEDGEMENTS493市场趋势显著对各种方法进行分析全球采购方支出分析公共部门市场总值相较于2020年有收缩，但从2017年至2021年市场总值有7%的增长。*本图中前十的国家以2021年的数据为依据，按字母顺序排列为：孟加拉、布基纳法索、刚果民主共和国、埃塞俄比亚、马拉维、莫桑比克、尼日利亚、坦桑尼亚、乌干达和赞比亚。公

2、共部门市场最大的前十个国家所占份额8%$205M$263M2002020217%49%56%53%53%60%51%44%47%47%40%$205M$246M$254M$285M$263M前十国家其他中低收入国家200202021基于2021年CYP出货量的各种避孕方法市场份额39%18%17%14%10%0.6%0.6%0.1%皮埋铜制IUDs口服避孕药-复方&纯孕激素注射避孕药物男用避孕套紧急口服避孕药含激素IUDs女用避孕套第一次在报告中增加本方法就2020-2021的CYP出货量而言增长最大$108MUNFPA在2021财年的避孕药具采购总

3、支出比2020财年减少了34%。主要原因是受新冠疫情影响，2021年英国外交、联邦和发展事务部（FCDO）对UNFPA的资金大幅减少。$35MUSAID在2021财年的避孕药具采购总支出比2020财年减少了24%。在2017财年至2021财年的典型波动范围内。2021年计划生育态势2021年计划生育态势4供应商发货分析2022年计划生育市场报告（FamilyPlanningMarketReport）介绍了2017年至2021年83个中低收入国家（LowerMiddleIncomeCountry，LMIC）1公共部门避孕市场概况。此前的市场报告侧重于69个FP2020重点国家，而今年的报告在地理

4、范围上做出了更新，涵盖了83个中低收入国家，地理范围进一步扩大，这些国家现已纳入FP2030于2021年宣布的性与生殖健康（SexualAndReproductiveHealth，SRH）社区新型全球伙伴关系与衡量架构中。1这83个中低收入国家按照截至2020年的世界银行收入分类进行定义。有关FP2030将报告数据的中低收入国家的更多信息，请参见：https:/fp2030.org/sites/default/files/Data-Hub/FP2030_DataReport_v5.pdf。请注意，FP2030报告涵盖82个中等收入国家，比计划生育市场报告涵盖的83个国家少一个。在一定程度上，由

5、于难以获取数据，FP2030目前未报告西撒哈拉（之前是69个FP2020重点国家之一）的相关数据。然而，在与FP2030协商后，CHAI和RHSC将西撒哈拉纳入了计划生育市场报告的范围内，因此共涵盖83个中低收入国家。为确保国家范围在报告所涵盖的所有年份中保持一致，从供应商处收集了2017-2021年83个范围内国家的历史发货数据。2IUD是宫内节育器的缩写。由于公开的激素型IUD价格于2021年首次纳入UNFPA避孕价格指数，因此激素型IUD今年首次被纳入计划生育市场报告。3此报告长期以来使用生殖健康交流中心（ReproductiveHealthInterchange，RHI）的数据来估计男

6、用避孕套市场的规模。由于男用避孕套市场相当分散，RHI长期以来针对该避孕方法提供了较高的可见性。此外，RHI数据也一直用于评估计划生育市场报告所涵盖的所有避孕方法的相对可见性。然而，2020年9月，SRH社区从RHI平台转移到了生殖健康用品可视化系统(RHViz)。因此，2022年计划生育市场报告现采用RHViz数据进行男用避孕套数量及市场可见性计算。有关详细信息，请参见附录C。4夫妻避孕年(CYP)是指避孕方法在一年内提供的估计避孕效果（例如，120只避孕套可为一对夫妻提供一年的避孕效果）。对于所有CYP计算，此报告均采用USAID最近发表的CYP因子。有关详细信息，请参见附录C。本报告范围

7、内的公共部门数量是指由公共部门采购方采购的数量，如美国国际开发署（UnitedStatesAgencyforInternationalDevelopment，USAID）和联合国人口基金（UnitedNationsPopulationFund，UNFPA）以及83个中低收入国家的卫生部、政府关联采购方及社会营销组织（SocialMarketingOrganization，SMO）。计划生育市场报告根据供应商报告的历史发货数据，分析了所有基于产品的现代避孕方法的采购趋势。该发货数据采集自17家供应商，避孕方法涵盖女用避孕套、皮埋、避孕注射剂、宫内节育器（IntrauterineDevice，IU

8、D）（含铜及激素）2、口服避孕药（复方及纯孕激素）以及紧急口服避孕药。男用避孕套的分析结果基于生殖健康用品可视化系统（ReproductiveHealthSuppliesVisualizer，RHViz）中的发货数据。3发货数据提供了对避孕产品历史采购情况的深入洞察，但这并不一定等同于对避孕产品的实际需求，因为采购行为是由可用资金及产能等关键因素所决定的。2021年，公共部门市场价值相对于2020年下降了8%，但仍高于2017-2019年的水平。相对于2020年，2021年的市场容量也下降了15%。由于方法特定的趋势，从2020年至2021年，发运至公共部门市场的避孕产品的夫妻避孕年（Coup

9、leYearsofProtection，CYP）4也下降了13%。从2020年到2021年，公共部门市场在已出货CYP方面的缩减主要是由铜制IUD、避孕注射剂以及复方和纯孕激素口服避孕药的数量减少所导致的。与2017-2020年期间一样，长效可逆避孕方法（Long-ActingReversibleMethodsofContraception-LARC），包括皮埋、铜制IUD和激素型IUD）仍然是2021年公共部门市场已出货CYP的主要贡献者。虽然从2020年至2021年LARC在已出货CYP中的总体份额保持在58%不变，但LARC内各子类别的数据却有所变化：从2020年至2021年，皮埋和激素

10、型IUD的已出货CYP份额有所增加；与此同时，铜制IUD的已出货CYP份额有所下降。供应商发货分析5本节分析了2017年至2021年公共部门市场的发货量、价值（美元）和已出货CYP总量趋势。值得注意的市场趋势5除非另有说明，否则报告的币种为美元6私营部门避孕用品的使用并未计入这些市场份额数据。此外，一些从孟加拉国和印度等市场的国内供应商处采购的产品可能未包含在参与供应商的发货数据中。因此，还应注意的是，市场份额估计值仅基于参与供应商的可用发货数据。有关孟加拉国和印度市场的更多详细信息，请参见附录E。7 如前所述，计划生育市场报告基于参与供应商的数据，介绍了孟加拉国的避孕用品采购趋势概况。但是，

11、除计划生育市场报告中记录的参与供应商外，孟加拉国市场上还活跃着其他供应商（有关更多详细信息，请参见附录E）。8由于铜制IUD的保质期较长（约3-7年）且避孕周期也较长（放置后最长可达12年），其采购周期可能并非总是与FP报告的年度时间表一致。各国可能会在一年内采购大量铜制IUD，并在接下来的数年内不再采购。以美元计，公共部门市场总值从2020年的2.85亿美元收缩至2021年的2.63亿美元，但仍高于2017-2019年的水平。由于所采购的避孕用品组合发生变化，已出货CYP数据也在2020年至2021年期间有所下降。83个中低收入国家的公共部门避孕市场总值从2017年的2.05亿美元5增加到2

12、021年的2.63亿美元（附件1）。虽然在2017年至2020年间市值每年都在增长，但在2020年达到峰值后，市值从2.85亿美元下降到2021年的2.63亿美元，下降了8%。然而，2021年的2.63亿美元市值仍高于2017年至2019年的年度市值（附件1）。从2020年到2021年，已出货CYP的数据也有所下降，从2020年的1.18亿下降到2021年的1.03亿（附件3）。CYP下降了13%，这主要是由于铜制IUD数量减少，这种产品成本相对较低，但CYP因子却相对较高。从2020年到2021年，铜制IUD的已出货CYP下降了900万。从2020年至2021年，避孕注射剂（已出货CYP下降

13、600万）以及复方和纯孕激素口服避孕药（已出货CYP下降200万）的已出货CYP同样有所下降。从2020年至2021年，皮埋的已出货CYP也稍有下降（下降40万），但从历史数据来看，皮埋的已出货CYP始终保持上升趋势。但男用避孕套（增加200万）和激素型IUD（增加50万）的已出货CYP有所增加，部分抵消了这一下降势头。就2017年至2021年间的地区趋势而言，撒哈拉以南非洲地区的市场份额基本保持不变，从2017年56%的低位上升至2019年65%的高位（附件7）。2020年至2021年，亚太地区的市场份额增加了4个百分点，达到28%，但在2017-2021年期间，该地区的市场份额保持相对恒定

14、，早在2017年便已达到过28%的高位（附件7）。在本报告所涉及的公共部门市场中，610个最大的国家（就市值而言）占2021年整体市值的50%以上，其中孟加拉国7约占公共部门市场份额的19%（附件8、9）。尽管相对于2020年，2021年公共部门整体市值有所收缩，但10个最大国家的市值从2020年的1.51亿美元增加到了2021年的1.59亿美元（附件9）。虽然排名前十的市场名单逐年变化，但从2017年至2021年，孟加拉国、埃塞俄比亚、尼日利亚、坦桑尼亚和乌干达这五个国家每年都高居排名前十的市场中。值得注意的避孕手段趋势从2020年到2021年，市值方面的缩减主要是由避孕注射剂以及复方和纯孕

15、激素口服避孕药的数量减少所导致的。相比于2020年，2021年的已出货CYP也有所下降，这是由2021年复方和纯孕激素口服避孕药、铜制IUD和避孕注射剂的数量减少所导致的。与前几年相比，2021年激素型IUD的已出货CYP显著增加。2021年，铜制IUD的数量连续第三年下降，与2020年相比下降了33%（附件2）。具体而言，铜制IUD的采购量从2020年的600万件下降至2021年的400万件（附件2）。减少的数量与2021年整体市值（下降50万美元）的小幅下降相当，这是因为铜制IUD的单位成本相对较低（附件1、4）。但由于每件铜制IUD的CYP因子相对较高，铜制IUD数量的减少对已出货CYP

16、产生了重大影响，导致铜制IUD的已出货CYP在2020年至2021年期间下降了900万（附件3、4）。从2020年至2021年，尼日利亚、印度尼西亚、肯尼亚和乌兹别克斯坦等国家是导致铜制IUD市场下降的主要贡献者。其中一些国家在前一至两年采购了明显更多的铜制IUD，表明2021年铜制IUD数量的下降可能部分与采购周期有关。8供应商发货分析6从2020年至2021年，激素型IUD类别有所增加。具体而言，随着准备好采取这种方法的国家开始引入这种方法并扩大使用规模，激素型IUD的已出货CYP从2020年的10万增加到2021年的60万。9在2020年达到6800万美元的高位后，避孕注射剂的市值在20

17、20年至2021年下降了31%，达到4700万美元（附件1）。从2020年至2021年，避孕注射剂的发货量也从8500万支降至5800万支（附件2）。在2020年至2021年的避孕注射剂总体下降量中，孟加拉国的下降量约占40%。孟加拉国在2020年采购了明显更多的避孕注射剂，因此2021年孟加拉国避孕注射剂采购量的下降可能是采购周期以及新冠疫情所致。供应及资金中断导致了避孕注射剂市场遭到干扰，这可能也是促使这一数据在2021年有所下降的原因。9激素型IUD引进工作得到了激素型IUD获取小组的支持，该小组是一个由政府、出资方、制造商、采购机构（UNFPA和USAID/GHSC-PSM）、研究人员

18、和服务提供伙伴组成的全球合作联盟，旨在通过确保提供价格合理、质量有保证的产品来促进市场可持续发展，同时为准备引进该方法及扩大其使用规模的国家（例如，政府对该方法表现出浓厚兴趣、制定引进计划等）提供支持，从而扩大中低收入国家获得激素型IUD的机会。有关更多信息，请参见激素型IUD获取机会门户网站(https:/www.hormonaliud.org/)。复方和纯孕激素口服避孕药的市值从2020年的6600万美元下降到2021年的5500万美元，下降了16%（附件1）。口服避孕药的发货量也从2020年的2.83亿下降到2021年的2.57亿（附件2）。多个国家的口服避孕药采购量有所下降，其中津巴布

19、韦最为突出。导致上述结果的潜在驱动因素包括正常的采购周期波动，以及过去几年中因供应链挑战而导致的运输相关困难。据报告，这些因素导致部分国家口服避孕药到货延迟，从而影响了口服避孕药的后续发货量和发货时间。注：虽然采购周期波动和上述其他因素促成了2020年至2021年的市场趋势，但形成2021年市场格局的另一个值得注意的因素是可用的避孕用品采购资金减少。这一驱动因素将在后续的“全球采购方支出分析”章节中进一步阐述。供应商发货分析7MethodYear over year 2020-2021*Compound annual growth rate 2017-2021*Condoms-Male33%2

20、1%Condoms-Female-29%-14%Injectables-31%0.3%Orals-Emergency-7%12%Orals-Combined&Progestin Only-16%-2%Hormonal IUDs785%55%Copper IUDs-22%4%Implants4%14%Total-8%7%*Year over year(YOY):change in the value of the public-sector market between 2020-21*Compound Annual Growth Rate(CAGR):(final value/beginnin

21、g value)(1/number of years)-1Note:The sum of individual stacked bars for all exhibits may differ slightly from totals due to rounding.Additionally,year over year and compound annual growth rate numbers are calculated throughout the report using actual values,not the rounded values in the chart.Some

22、differences exist in the historical data for 2017-2020 in this version of the report versus previous versions due to the different geographic scope of the report this year(83 LMICs)v.last year(69 FP2020 countries),different supplier scope,as well as some supplier or RH Viz revisions to historical da

23、ta,based on updated information.Sources:1 Historical supplier-reported shipment data;2 RH Viz shipment data,retrieved August 2022;3 UNFPA Contraceptive Price Indicator,20172021Exhibit 1:Value of the public-sector market(USD)$0M$50M$100M$150M$200M$250M$300M202182017Total Market Size(Millio

24、ns USD)$70M$1M$0.2M$59M$2M$46M$10M$15M$89M$4M$0.3M$52M$3M$66M$6M$27M$96M$3M$0.3M$60M$3M$55M$10M$27M$113M$2M$0.2M$66M$4M$68M$8M$24M$117M$2M$1.3M$55M$3M$47M$6M$32M$205M$246M$254M$285M$263MImplantsCopper IUDsHormonal IUDsOrals-EmergencyInjectablesCondoms-FemaleCondoms-MaleOrals-Combined and Progestin O

25、nlySUPPLIER SHIPMENT ANALYSIS8MethodYear over year 2020-2021Compound annual growth rate 2017-2021Condoms-Female-31%-13%Injectables-32%-0.3%Orals-Emergency-4%12%Orals-Combined&Progestin Only-9%4%Hormonal IUDs785%55%Copper IUDs-33%-4%Implants-1%13%Total-15%3%Note:The sum of individual stacked bars for

26、 all exhibits may differ slightly from totals due to rounding.Additionally,year over year and compound annual growth rate numbers are calculated throughout the report using actual values,not the rounded values in the chart.Some differences exist in the historical data for 2017-2020 in this version o

27、f the report versus previous versions due to the different geographic scope of the report this year(83 LMICs)v.last year(69 FP2020 focus countries),different supplier scope,as well as some supplier or RH Viz revisions to historical data,based on updated information.Sources:1 Historical supplier-repo

28、rted shipment data;2 RH Viz shipment data,retrieved August 2022.Exhibit 2:Total public-sector market volumes(male condoms excluded*)0 M100 M200 M300 M400 M500 M202182017Shipment Volumes (Millions)8M5M0.02M218M8M59M22M10M12M0.02M213M9M82M13M12M9M0.03M251M9M71M22M14M6M0.01M283M14M85M18M14M4

29、M0.12M257M13M58M13M320M340M373M420M358MImplantsCopper IUDsHormonal IUDsOrals-EmergencyInjectablesCondoms-FemaleOrals-Combined and Progestin OnlySUPPLIER SHIPMENT ANALYSISMale condom shipment values(billions)200202021Year over year 2020-2021Compound annual growth rate 2017-2021 0.65B 1.21B

30、 1.17B 1.04B 1.28B23%18%*Male condoms are shown separately because the source of the shipment data is RH Viz,whereas all other methods are supplier-reported.See Appendix C for further details.9MethodYear over year 2020-2021Compound annual growth rate 2017-2021Condoms-Male23%18%Condoms-Female-31%-13%

31、Injectables-30%0%Orals-Emergency-4%12%Orals-Combined&Progestin Only-10%4%Hormonal IUDs785%55%Copper IUDs-33%-4%Implants-1%12%Total-13%5%Exhibit 3:CYPs shipped to the public-sector market0 M30 M60 M90 M120 M150 M202182017CYPs Shipped(Millions)26M31M57M0.1M15M0.5M20M0.1M10M22M0.1M15M14M0.4M

32、5M0.2M83M133M34M42M0.1M17M0.4M17M0.2M10M121M41M28M0.1M19M0.7M21M0.2M9M118M40M19M0.6M17M0.7M14M0.1M11M103MImplantsCopper IUDsHormonal IUDsOrals-EmergencyInjectablesCondoms-FemaleCondoms-MaleOrals-Combined and Progestin OnlySUPPLIER SHIPMENT ANALYSISNote:The sum of individual stacked bars for all exhi

33、bits may differ slightly from totals due to rounding.Additionally,year over year and compound annual growth rate numbers were calculated throughout the report using actual values,not the rounded values in the chart.Some differences exist in the historical data for 2017-2020 in this version of the re

34、port versus previous versions due to the different geographic scope of the report this year(83 LMICs)v.last year(69 FP2020 focus countries),different supplier scope,as well as some supplier or RH Viz revisions to historical data,based on updated information.Sources:1 Historical supplier-reported shi

35、pment data;2 RH Viz shipment data,retrieved August 2022;3 USAID,“Couple-Years of Protection(CYP)”.10Exhibit 4A:Cost per CYP by method per duration of use(USD)Exhibit 4B:Cost per CYP by method in 2021(USD)SUPPLIER SHIPMENT ANALYSIS MethodUnits per CYPUnit Cost Cost per CYP 2017 2018 2019 2020 2021 20

36、17 2018 2019 2020 2021 Condoms-Female 120.00$0.46$0.47$0.44$0.43$0.44$55.32$56.88$53.28$51.48$52.32 Condoms-Male 120.00$0.02$0.02$0.02$0.02$0.02$2.71$2.64$2.72$2.75$2.98 Injectables-1 month 13.00$0.85$0.85N/AN/AN/A$11.05$11.05N/AN/AN/A Injectables-2 month 6.00$1.15$1.15$1.15$1.15$1.15$6.90$6.90$6.90

37、$6.90$6.90 Injectables-3 month 4.00$0.77$0.79$0.75$0.77$0.77$3.09$3.16$3.00$3.07$3.09 Orals-Combined 15.00$0.27$0.24$0.23$0.23$0.21$4.01$3.56$3.51$3.38$3.17 Orals-Progestin Only 12.00$0.32$0.29$0.29$0.30$0.28$3.80$3.52$3.47$3.60$3.40 Orals-Emergency 20.00$0.26$0.28$0.40$0.26$0.25$5.14$5.52$7.98$5.18

38、$5.00 Implants-3 Year 0.40$8.50$8.50$8.50$8.50$8.50$3.40$3.40$3.40$3.40$3.40 Implants-5 Year 0.26$8.50$8.50$8.50$8.50$8.50$2.24$2.24$2.24$2.24$2.24 IUDs(hormonal)0.21 N/AN/AN/AN/A$10.84N/AN/AN/AN/A$2.26 IUDs(copper)0.22$0.31$0.30$0.31$0.37$0.43$0.07$0.07$0.07$0.08$0.09Note:N/A indicates method was n

39、ot listed on the UNFPA Contraceptive Price Indicator.Implant pricing in this exhibit uses the IAP implant price.2021 is the first year that UNFPA Contraceptive Price Indicator has listed separate prices for the 3-year and 5-year implants,but to maintain historical consistency,we continue to use the$

40、8.50 IAP implant price for this illustrative cost per CYP calculation.Sources:1 UNFPA Contraceptive Price Indicator,20172021;2 USAID,“Couple-Years of Protection(CYP)”,3 IAP Implant Price.Cost Per CYP By Method in 2021 (USD)$0$10$20$30$40$50$60 Condoms-Female Injectables-2 month Orals-Emergency Impla

41、nts-3 Year Orals-Progestin Only Orals-Combined Injectables-3 month Condoms-Male IUDs(hormonal)Implants-5 Year IUDs(copper)$0.09$2.24$2.26$2.98$3.09$3.17$3.40$3.40$5.00$6.90$52.3211LARCs as a percentage of CYPs shipped20020202158%66%63%58%58%Exhibit 5:CYP mix(in terms of CYPs shipped)in th

42、e public-sector market0%20%40%60%80%100%202182017CYP Mix31%27%0.1%18%0.5%0.2%17%7%83M23%43%11%0.1%0.3%15%0.1%8%28%35%14%0.4%0.1%14%0.1%8%34%24%16%0.6%0.1%18%0.1%8%133M121M118M39%18%17%0.6%0.6%14%0.1%10%103MCYPsshippedCYPs MixImplantsCopper IUDsHormonal IUDsOrals-EmergencyInjectablesCondom

43、s-FemaleCondoms-MaleOrals-Combined and Progestin OnlySUPPLIER SHIPMENT ANALYSISNote:Some differences exist in the historical data for 2017-2020 in this version of the report versus previous versions due to the different geographic scope of the report this year(83 LMICs)v.last year(69 FP2020 focus co

44、untries),different supplier scope,as well as some supplier or RH Viz revisions to historical data,based on updated information.LARCs as a percentage of CYPs shipped were calculated using actual values,not the rounded values in the chart.Sources:1 Historical supplier-reported shipment data;2 RH Viz s

45、hipment data,retrieved August 2022;3 UNFPA Contraceptive Price Indicator,20172021;4 USAID,“Couple-Years of Protection(CYP)”.12LARCs as a percentage of market value20020202135%38%39%40%46%Exhibit 6:Market share per method in the public-sector market(USD)SUPPLIER SHIPMENT ANALYSISNote:Some

46、differences exist in the historical data for 2017-2020 in this version of the report versus previous versions due to the different geographic scope of the report this year(83 LMICs)v.last year(69 FP2020 focus countries),different supplier scope,as well as some supplier or RH Viz revisions to histori

47、cal data,based on updated information.LARCs as a percentage of market value were calculated using actual values,not the rounded values in the chart.Sources:1 Historical supplier-reported shipment data;2 RH Viz shipment data,retrieved August 2022;3 UNFPA Contraceptive Price Indicator,20172021.0%20%40

48、%60%80%100%202182017$205M$246M$254M$285M34%1%0.1%29%1%23%5%7%36%2%0.1%21%1%27%3%11%38%1%0.1%24%1%21%4%10%40%1%0.1%23%1%24%3%8%45%1%0.5%21%1%18%2%12%$263MImplantsCopper IUDsHormonal IUDsOrals-EmergencyInjectablesCondoms-FemaleCondoms-MaleOrals-Combined and Progestin OnlyMarketValue13Exhibi

49、t 7:Market share of public sector by region(USD)0%20%40%60%80%100%202182017$205M$246M$254M$285M28%2%2.3%56%11%27%2%1.7%60%9%24%2%3%65%6%24%1%1.3%64%10%$263M28%1%1.4%62%7%MarketValueLatin America&CaribbeanAsia&PacificSub-Saharan AfricaFinal Destination Country Not SpecifiedMiddle East&Nort

50、h AfricaNote:Public-sector,regional market share shown in the graph above is influenced by the relative distribution of LMICs,the majority of which are located in Sub-Saharan Africa.Only a small number of countries from both the Latin America&Caribbean and Middle East&North Africa regions are includ

51、ed among the 83 LMICs;trends across the whole of these regions are not captured above.“Destination country not specified”indicates that shipments were received in warehouses for later distribution to LMICs.Some differences exist in the historical data for 2017-2020 in this version of the report vers

52、us previous versions due to the different geographic scope of the report this year(83 LMICs)v.last year(69 FP2020 focus countries),different supplier scope,as well as some supplier or RH Viz revisions to historical data,based on updated information.Sources:1 Historical Supplier-Reported Shipment Dat

53、a;2 RH Viz Shipment Data,retrieved August 2022;3 UNFPA Contraceptive Price Indicator,20172021 SUPPLIER SHIPMENT ANALYSIS14Exhibit 8:Top ten countries in terms of value,2021Exhibit 9:Value of 10 largest public-sector countries compared to value of all other countries combined 0%5%10%15%20%25%30%35%40

54、%Other LMICs Tanzania Malawi Zambia Mozambique Burkina Faso Ethiopia Uganda Nigeria Bangladesh 40%19%8%7%6%4%3%4%3%3%3%Democratic Republic of CongoNote:Some differences exist in the historical data for 2017-2020 in this version of the report versus previous versions due to the different geographic s

55、cope of the report this year(83 LMICs)v.last year(69 FP2020 focus countries),the transition from RHI to RH Viz for male condom data,as well as a few supplier-reported revisions to historical data,based on updated information.Sources:1 Historical supplier-reported shipment data;2 RH Viz Shipment Data

56、,retrieved August 2022;3 UNFPA Contraceptive Price Indicator,20172021.$0M$50M$100M$150M$200M$250M$300M202182017$205M$246M$285M$254M$137M$109M$135M$119M$263M$159M$105M$151M$133M$100M$105MMarket Size(Millions USD)Top 10 Countries*Other LMICs*Top countries in this graph are defined by 2021 d

57、ata and,in alphabetical order are:Bangladesh,Burkina Faso,Democratic Republic of Congo,Ethiopia,Malawi,Mozambique,Nigeria,Tanzania,Uganda and Zambia.SUPPLIER SHIPMENT ANALYSIS15全球采购方支出分析本节重点介绍来自UNFPA采购事务处及USAID“避孕用品与避孕套发货概述”(OverviewofContraceptiveandCondomShipments)报告中的数据10，以便了解这两个主要的全球采购方在83个中低收入国

58、家公共部门市场的历史避孕用品采购支出情况。10在2018年计划生育市场报告发表之前，CHAI和RHSC采用RHI的数据进行全球采购方支出分析。此后，计划生育市场报告采用了来自UNFPA采购事务处及USAID“避孕用品与避孕套发货概述”报告中的数据。11从2020年至2021年，全球采购方支出的下降幅度大于根据供应商发货数据得出的83个中低收入国家公共部门市值的下降幅度，部分原因在于供应商发货数据包括孟加拉国和印度等国家的采购数据，这些国家利用部分国内资金来采购避孕用品，而全球采购方支出数据中并未包含这类国内资金。此外，供应商发货分析采用UNFPA避孕价格指数定价来计算总市值，因为这是定期更新的

59、公开数据来源，但实际定价可能因国家、产品的不同而存在一些差异。12https:/www.unfpa.org/press/statement-uk-government-funding-cuts13https:/www.unfpa.org/press/support-france-safeguard-health-and-lives-millions-women-and-girls?page=27,https:/www.state.gov/u-s-engagement-with-the-un-population-fund-unfpa/14https:/www.unfpa.org/unfpa-s

60、upplies-annual-report-202115USAID关于避孕用品发货的数据取自“2021财年避孕用品与避孕套发货概述报告”。2021财年的报告反映了计划生育供资情况，但不包括HIV/AIDs资助避孕套；因此，我们排除了2017财年至2021财年的女用和男用避孕套的市值，以比较不同年份的同一数据集。USAID报告可在此获得：https:/www.usaid.gov/sites/default/files/documents/CC_FY21.pdf16USAID财年（FiscalYear，FY）自当年10月1日起算，直至次年9月30日。自2018财年以来，USAID开始在“避孕用品与

61、避孕套发货概述”报告中分享相关数据，这类数据基于订单交付年份，而不是产品发运至各国的年份。17USAID的“自力更生之旅”战略旨在促进与东道国政府的合作，以加强地方能力、调动公共和私营部门收入并加速以企业为驱动的发展https:/www.usaid.gov/documents/1870/journey-self-reliance-fact-sheet.在2017-2021期间，UNFPA在避孕用品方面的支出于2020财年达到顶峰，随后在2021财年大幅下降。从2020财年至2021财年，USAID的支出也有所下降，但仍保持在从2017-2021五年周期内观察到的典型波动范围内。UNFPA在避孕

62、用品采购方面的支出总额（包括UNFPA项目采购和第三方采购）从2020财年的1.63亿美元下降至2021财年的1.08亿美元，下降了34%（附件10）。11然而，在2021财年，UNFPA在避孕用品采购方面的支出仍高于2017年9700万美元的五年周期低位（附件10）。UNFPA在2021财年的避孕用品采购支出之所以有所下降，是因为UNFPA当年的供资情况发生了重大变化。特别是，由于新冠疫情所带来的经济挑战，英国宣布在2021年大幅度削减其对官方国际发展援助项目（OfficialDevelopmentActivities-ODA）的供资，其中包括将其对UNFPA物资供应项目的供资削减约85%。

63、12其他政府（如法国和美国）13、基金会和私人捐助者的确在减轻资金削减所带来的影响方面有所帮助；然而，这些捐款不足以满足所有项目需求，也不足以完全弥补2021年的资金缺口。14虽然从2020财年到2021财年，UNFPA在避孕用品采购方面在整体支出大幅下降，但第三方采购占UNFPA支出总额的百分比从2020财年的9%增加到了2021财年的20%。具体而言，从2020财年至2021财年，第三方采购增加了约700万美元（增长50%），而项目采购减少了约6200万美元（下降42%）。在2017财年至2021财年期间，第三方采购占UNFPA年度中低收入国家总支出的百分比每年都在10%至20%之间波动。

64、对于USAID，2021财年（不包括男用和女用避孕套）1515的避孕用品采购年值为3500万美元，较2020财年下降了24%（附件11）。16从2017财年至2021财年，USAID支出每年在3400万美元至5000万美元之间波动。USAID在2021财年的支出在此范围内。2021年USAID避孕用品与避孕套发货概述报告强调了导致2020财年至2021财年下降趋势的几个关键驱动因素，包括国家资金来源的变化（例如，某些国家转变为增加国内筹资）、采购周期引起的波动以及新冠疫情。USAID在避孕用品采购方面的支出仍然比较分散，并由国家特派团决定。正如USAID报告中所提到的，随着USAID继续实施其

65、“自力更生之旅”(JourneytoSelf-Reliance)战略，USAID在某些国家的驻外使团可能会提交较少的避孕用品采购资金请求。17全球采购方支出分析16Exhibit 10:UNFPA procurement value contraceptives to LMICs(in USD)Exhibit 11:USAID procurement value(excluding male and female condoms)contraceptives to LMICs(in USD)$0M$50M$100M$150M$200M202182017Shipment V

66、alues to FP2020(Millions USD)$97M$137M$162M$163M$108MUNFPAUSAID$0M$10M$20M$30M$40M$50M202182017$34M$50M$38M$35M$46MShipment Values to FP2020(Millions USD)Sources:1 UNFPA Procurement Services Branch data FY2017-FY2021;2 USAID“Overview of Contraceptive and Condom Shipments”reports,FY 2017 F

67、Y2021.2020-2021 YOY:-34%2017-2021 CAGR:+2%2020-2021 YOY:-24%2017-2021 CAGR:+1%GLOBAL PROCURER SPEND ANALYSIS 17虽然2021财年全球采购方在避孕用品采购方面的支出有所下降（这主要是由2021年UNFPA物资供应项目供资削减导致的），但预计2022财年及未来几年将出现一些回弹。UNFPA已在为2022财年及未来几年积极筹款，以抵消2021财年避孕用品采购支出方面的下降势头（这主要是由于2021年英国外交、联邦和发展事务部（Foreign,CommonwealthandDevelopmen

68、tOffice，FCDO）削减资金造成的）。经过不断努力，UNFPA的预算很可能将在未来回弹，达到与2021年之前相当的水平。例如，作为其前瞻性综合预算的一部分，UNFPA表示，UNFPA对2022-2025财年的整体收入预测预计将与2018-2021年收到的实际捐款相当。18根据附件10，UNFPA在2018-2021财年的平均避孕用品采购支出约为每年1.42亿美元。因此，假设UNFPA的避孕用品采购符合UNFPA的整体收入预测，这意味着UNFPA在未来几年的年均避孕用品采购支出将回弹至高于2021财年的水平。然而，鉴于各国的经济形势严峻，长期出资方供资仍然存在一些不确定性。例如，2022年

69、11月，英国宣布削减20.5亿美元的援助预算，而且预计明年将进一步进行削减。19由于经济形势严峻，这是英国三年来第三次削减援助预算。18https:/www.unfpa.org/press/statement-executive-director-unfpa-integrated-budget-2022-2025-second-regular-session19https:/ MARKETS VISIBILITY PROJECT ACKNOWLEDGEMENTS30 The procurement of products used for sterilization such as tubal

70、 rings are not covered in this reportAbout the Global Markets Visibility Project The Global Markets Visibility Project is a landmark initiative that has provided the reproductive health community with detailed assessments of the public-sector family planning market across the 69 FP2020 focus countri

71、es(and,this year,all LMICs)since 2015.The initiative provides insightful and strategic outputs for donors,MOHs,implementing organizations,and suppliers to develop and implement more effective strategies to enable users in the LMICs to access family planning products and services.This report is a col

72、laboration between CHAI and the RHSC.The initial 2015 report comprised of data from 11 manufacturers.Each manufacturer entered a formal MOU with CHAI or provided their information through collaborations with the then Generic Manufacturers Caucus for Reproductive Health(GEMs)and i+solutions.Since the

73、n,coverage has expanded,and today there are 17 suppliers participating in the project.Market Definition,Scope,and CoverageThe total public-sector market referenced in this report only includes data for the public sector,which is defined as volumes purchased by public sector procurers such as the Uni

74、ted States Agency for International Development(USAID)and United Nations Population Fund(UNFPA),ministries of health,government affiliated procurers as well as social marketing organizations(SMOs).Although significant efforts have been made to collect as much data as possible,it should be noted that

75、 the data in this report may not represent the entirety of contraceptive procurement for the public sector.This report includes data from most,but not all,suppliers associated with these markets.About the Participating Suppliers(in alphabetical order)BayerBayer is a Germany-based life science compan

76、y with core competencies in health care and agriculture.Its contraceptive product portfolio includes contraceptive implants,hormonal IUD,oral contraceptives,and injectables.CiplaCipla Limited is an India-based generic manufacturer with over 1,500 products in the areas of respiratory diseases,HIV/AID

77、S,malaria,MDRTB,and reproductive health.Its contraceptive product portfolio includes emergency contraceptives and combined oral contraceptives.It also manufactures misoprostol.Corporate ChannelsCorporate Channels India Pvt.Ltd.(CCIPL)is a manufacturer of female contraceptive devices based in India,s

78、ince 1993.CCIPLs contraceptive product portfolio includes several IUDs(EVES Copper T380A,TCu380A Ultra Loadezy,PPIUD,Cu 375,and Cu375SL)that provide long-acting reversable contraception,and Tubal Rings30 that provide permanent contraception for women.CCIPLs Copper T 380A IUD has been prequalified by

79、 WHO/UNFPA for global supply,and several products(EVES Copper T380A,EVES Cu 375 and EVES Cu 375 SL)have been CE marked.CR ZizhuChina Resources Zizhu Pharmaceutical Co.,Ltd.(CR Zizhu)is a manufacturer of reproductive health products based in China.Its contraceptive product portfolio includes emergenc

80、y oral contraceptives and combined oral contraceptives.CR Zizhu also manufactures misoprostol and several APIs including levonorgestrel.CupidCupid Limited is a manufacturer of both male and female condoms based in India.Its services include contract manufacturing(e.g.,Playboy condoms,Trust condoms)a

81、nd research and development,as well as the marketing and manufacturing of its own branded products.GLOBAL MARKETS VISIBILITY PROJECT ACKNOWLEDGEMENTS20Female Health CompanyFemale Health Company is the global public sector division of Veru Healthcare focusing on urology and oncology,headquartered in

82、Miami,Florida,USA.The Female Health Company is the manufacturer of the FC2 female condom and focuses on the global public health sector business.FC2 is approved by the US FDA and WHO pre-qualified for offering dual protection against sexually transmitted infections and unintended pregnancy.InceptaIn

83、cepta Pharmaceuticals Ltd.is a pharmaceutical company based in Dhaka,Bangladesh that manufactures and markets generic drugs.Incepta has a portfolio of more than 600 generic products in 1,100+presentations,across various therapeutic areas.Incepta currently exports its products to 83 countries around

84、the world.Its contraceptive product portfolio includes oral(combined and progestin only)and injectable contraceptives.Medicines360 Medicines360 is a U.S.-based,nonprofit global womens health pharmaceutical company that seeks to catalyze equitable access to medicines and devices through product devel

85、opment,policy advocacy,and collaboration with global and U.S.partners.Medicines360s portfolio consists of a hormonal IUD marketed as Avibela in LMICs and Liletta in the U.S.Organon&Co.Organon&Co.is a U.S.-based healthcare company.Its contraceptive product portfolio includes contraceptive implants(Im

86、planon NXT,which includes a prefilled sterile applicator),oral contraceptives(Exluton and Marvelon)for LMICs public-sector markets,and oral contraceptives(Cerezette,Exluton,Marvelon,Mercilon,and for USA/CAN Zoely),contraceptive implants(Implanon NXT)and the contraceptive vaginal ring(NuvaRing)for ot

87、her markets.PfizerPfizer is a U.S.-based healthcare company.Its contraceptive product portfolio includes 3-month injectable DMPA IM(Depo-Provera)and 3-month injectable DMPA SC(Sayana Press).PregnaPregna is a manufacturer of contraceptive products based in India.Its contraceptive product portfolio in

88、cludes hormonal IUD(Eloira),copper IUDs,and tubal rings used for female sterilization.PT TunggalPT Tunggal Idaman Abdi(PT Tunggal)is a pharmaceutical company based in Jakarta,Indonesia,with a focus on reproductive healthcare.Its contraceptive product portfolio includes a monthly injectable,a three m

89、onthly injectable,a combined oral contraceptive,and an emergency oral contraceptive.Today,PT Tunggal exports to over 60 countries and in August 2021,its three monthly injectable Triclofem received WHO prequalified status.RenataRenata is a pharmaceutical company based in Bangladesh.Its contraceptive

90、product portfolio includes combined oral contraceptives,progestin-only oral contraceptives,and emergency oral contraceptive pills.Shanghai DahuaShanghai Dahua Pharmaceutical Co.,Ltd(Dahua)is a manufacturer of contraceptive implants based in China.On June 30th,2017,the World Health Organization(WHO)p

91、re-qualified Dahuas Levoplant(formerly known as Sino Implant II)for three years of use.SMBSMB is a manufacturer of medical devices,including copper IUDs and surgical sutures,based in India.Its key contraceptive products are IUDs,including Copper T 380A,TCu 380Ag,TCu 380 Plus,and SMB Cu 375.Techno Dr

92、ugsTechno Drugs Ltd.is a manufacturer of both human and veterinary medicines based in Bangladesh.Its contraceptive product portfolio includes combined oral contraceptives,implants,and injectables.For injectables,Techno Drugs served as a supplier to Helm AG previously.Viatris(Mylan)Viatris(Mylan)is a

93、 U.S.based healthcare company with over 7,500 marketed products.Its contraceptive product portfolio includes oral solids,injectables,and devices.GLOBAL MARKETS VISIBILITY PROJECT ACKNOWLEDGEMENTS21APPENDICESAPPENDIX A-83 LMICs:MARKET VOLUMES BY METHOD31 AND COUNTRY,20172021Exhibit A.1:83 LMICs-Contr

94、aceptive market volumes by method,2017 CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsAfghanistan 16,665,410 9,800 59,600 100,000 365,200 Algeria 1,488,982 Angola 12,000,000 22,000 530,600 18,000 1,807,419 Bangladesh 1,195,200 400,000 6,258,000 86,252,000 Belize Benin 368,399

95、34,900 30,600 Bhutan Bolivia 2,001,600 94,600 50,400 30,000 Burkina Faso 15,050,020 95,300 481,200 3,741,150 Burundi 17,500 169,980 Cabo Verde 254,880 Cambodia 1,929,600 40,056 900,000 60,000 7,082,236 Cameroon 6,658,400 95,200 327,000 41,500 298,080 Central African Republic 268,999 95,040 Chad Como

96、ros 1,267,200 2,520 40,000 150 60,480 Congo Dem Rep 840,000 364,828 2,143,580 1,380,220 Cote dIvoire 11,992,968 196,600 243,000 8,000 6,521,413 Djibouti 6,480 El Salvador 7,210,720 10,858 209,800 7,182 225,960 Eritrea 8,640,000 12,500 100,000 112,560 Ethiopia 57,600,000 1,107,134 7,436,988 440,000 1

97、0,794,948 Gambia 5,371,200 16,488 110,000 1,500 235,440 Ghana 250,256 106,000 11,500 3,183,960 Guinea 158,136 100,000 30,240 Guinea-Bissau 6,972,620 27,300 2,500 2,160 Haiti 69,455,900 4,116 863,400 647,304 Honduras 3,024,000 1,440 21,000 6,000 1,641,840 India 1,047,488 522,885 2,262,311 Indonesia K

98、enya 229,000 408,781 437,376 126,000 7,921,836 Kiribati 31 Female condoms are aggregated with male condoms and hormonal IUDs are aggregated with copper IUDs by country in order to protect data confidentiality.APPENDICES22Exhibit A.1:83 LMICs-Contraceptive market volumes by method,2017 CountryCondoms

99、-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsKyrgyz Republic Lao PDR 1,929,000 65,808 76,800 701,040 Lesotho 14,001,000 31,200 165,000 176,400 Liberia 2,853,000 36,100 319,000 5,760 Madagascar 256,618 3,012,800 295,019 1,288,800 Malawi 21,759,000 167,408 1,000,000 36,500 236,700 Mali 17,2

100、55,400 209,728 293,000 26,000 210,240 Mauritania 10,404 88,600 1,500 295,920 Mongolia 8,488,800 800 53,000 350,160 Morocco 720 10,000,001 Mozambique 56,748,000 60,016 1,373,600 23,600 3,278,160 Myanmar 35,136,646 18,936 6,108,125 200 16,446,928 Nepal 16,701,000 211,800 641,000 74,000 4,015,160 Nicar

101、agua 2,911,680 504 50,000 Niger 979,200 54,100 499,000 7,920 437,040 Nigeria 44,137,000 665,160 3,316,700 1,229,445 Pakistan 512,480 900 495,960 123,840 Papua New Guinea 669,600 30,000 22,000 4,000 82,720 Philippines Rwanda 1,631,200 84,062 8,200 13,200 68,400 Samoa Sao Tome and Principe 1,108,800 3

102、00 28,000 98,100 Senegal 67,864 160,000 139,140 Sierra Leone 19,728,000 230,400 332,650 16,000 1,087,240 Solomon Islands Somalia 2,500 3,500 South Sudan 11,340,000 25,016 150,000 20,000 Sri Lanka 4,056,620 65,500 50,000 3,589,760 Sudan 36,936 6,000 2,123,400 Tajikistan 4,687,200 142,000 613,440 Tanz

103、ania 4,320,180 798,920 2,830,850 177,000 2,885,763 Timor-Leste 1,080,000 20,000 Togo 8,466,200 67,388 140,000 5,000 25,002 Tunisia 1,000,800 Uganda 297,652 3,895,400 251,000 249,520 Ukraine Uzbekistan 13,217,540 718,989 APPENDICES23Exhibit A.1:83 LMICs-Contraceptive market volumes by method,2017 Cou

104、ntryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsVanuatu Vietnam 21,816,000 12,636 1,196,500 1,239,531 Western Sahara Yemen 5,304,960 64,288 445,000 Zambia 16,389,600 161,800 3,418,650 3,528,960 Congo 2,160,000 20,376 32,000 500 720 DPR Korea Egypt 40,032 375,045 Eswatini 32,415,00

105、0 18,406 107,650 5,017 Iran 120,000 73,600 Micronesia State of Palestine 1,944,000 Syria 1,440,000 7,500 Zimbabwe 64,653,000 60,496 1,399,200 10,000 12,716,941 Other LMIC Shipments 5,859,600 1,058,100 5,912,600 308,145 23,003,805 Total Volumes 675,719,880 8,247,551 58,533,857 4,897,954 226,409,613 A

106、PPENDICESSources:1 Historical Supplier-Reported Shipment Data;2 RH Viz Shipment Data,retrieved August 2022.24APPENDICESExhibit A.2:83 LMICs-Contraceptive market volumes by method,2018 CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsAfghanistan 16,500 307,750 224,480 Algeria 5,0

107、37,980 10,080 Angola 26,601,000 529,750 Bangladesh 12,355,200 793,064 15,194,000 720,000 105,801,680 Belize 864,000 20,000 3,000 45,360 Benin 12,966,000 38,100 38,000 2,250 Bhutan Bolivia 73,300 200,000 10,000 230,022 Burkina Faso 11,720,400 342,940 246,400 3,398,400 Burundi 22,039,200 4,000 126,400

108、 415,332 Cabo Verde 2,000,160 3,000 201,600 Cambodia 3,427,200 46,392 700,000 30,000 11,986,296 Cameroon 9,633,600 112,952 338,000 3,500 100,000 Central African Republic 12,960,000 4,800 108,200 738 39,648 Chad 1,008,000 38,846 187,000 5,000 Comoros 1,180,800 3,000 Congo Dem Rep 49,969,750 399,170 1

109、,343,100 370,560 Cote dIvoire 25,420,800 139,088 474,800 23,000 3,867,676 Djibouti 396,000 3,200 70,400 El Salvador 1,255,968 386,100 581,040 Eritrea 2,200 100,000 10,025 Ethiopia 35,004,720 1,205,446 7,753,455 600,000 7,896,030 Gambia 1,400 160,500 1,000 660,816 Ghana 33,221,400 282,314 2,179,000 3

110、0,500 2,827,200 Guinea 9,360,000 100,000 51,360 Guinea-Bissau 10,310,400 6,600 42,120 Haiti 85,745,640 34,016 1,827,000 2,000 100,212 Honduras 24,012,000 1,000 107,000 1,100 74,880 India 102,000 3,223,328 366,065 Indonesia 852,430 Kenya 2,000,000 379,232 470,124 101,225 12,791,937 Kiribati Kyrgyz Re

111、public 1,432,800 220,800 Lao PDR 600,000 242,000 12,500 660,600 Lesotho 8,192,600 7,644 15,000 10,000 116,682 Liberia 1,180,800 35,000 705,200 32,400 Madagascar 5,001,000 325,344 4,866,200 500 204,800 Malawi 166,785,600 223,260 4,947,825 1,250,484 25Exhibit A.2:83 LMICs-Contraceptive market volumes

112、by method,2018 CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsMali 13,067,620 56,576 1,578,800 8,757 1,063,635 Mauritania 5,700 86,800 87,840 Mongolia 5,508,000 6,200 28,000 420,000 Morocco Mozambique 86,133,400 231,648 3,291,800 97,816 51,120 Myanmar 49,103,686 88,540 2,889,1

113、25 54,200 14,847,143 Nepal 13,197,480 176,000 2,170,400 60,000 3,299,530 Nicaragua 11,164,300 2,854 12,000 Niger 849,600 170,940 914,200 658,002 Nigeria 42,934,272 1,023,764 4,731,600 151,800 2,146,764 Pakistan 758,016 10,000 100,000 486,525 Papua New Guinea 6,112,800 60,000 5,000 9,964 424,967 Phil

114、ippines 2,397,600 50,450 Rwanda 31,860,800 256,072 862,200 11,000 55,680 Samoa Sao Tome and Principe 1,112,832 500 26,000 67,080 Senegal 16,566,000 186,336 7,000 Sierra Leone 151,033 972,800 25,500 435,480 Solomon Islands Somalia 72,000 15,240 100,000 South Sudan 2,476,000 54,000 340,000 610,080 Sri

115、 Lanka 500 50,000 2,119,680 Sudan 720,000 51,264 4,000 Tajikistan 138,000 100,500 595,224 Tanzania 2,868,000 810,780 2,067,300 23,600 1,273,980 Timor-Leste 3,900 Togo 21,247,832 75,264 118,400 164,154 Tunisia 2,001,600 Uganda 124,701,400 811,576 5,469,525 248,500 4,369,950 Ukraine 21,033,000 Uzbekis

116、tan Vanuatu Vietnam 21,816,000 925,250 Western Sahara Yemen 1,303,200 37,440 1,093,600 51,700 30,000 Zambia 93,849,400 115,096 1,855,950 7,399,200 Congo 10,000 86,000 12,120 DPR Korea APPENDICES26Exhibit A.2:83 LMICs-Contraceptive market volumes by method,2018 CountryCondoms-Male&FemaleImplantsInjec

117、tablesIUDs-Copper&HormonalOralsEgypt 160,046 3,774,650 Eswatini Iran Micronesia State of Palestine 5,000 Syria 1,440,000 40,000 Zimbabwe 66,442,460 87,500 1,010,975 25,000 18,265,635 Other LMIC Shipments 4,179,902 1,263,200 7,977,325 156,180 9,714,060 Total Volumes 1,226,600,218 10,434,177 81,651,60

118、4 12,339,013 222,479,359 Sources:1 Historical Supplier-Reported Shipment Data;2 RH Viz Shipment Data,retrieved August 2022.APPENDICES27APPENDICESExhibit A.3:83 LMICs-Contraceptive market volumes by method,2019 CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsAfghanistan 4,002,00

119、0 7,800 617,000 175,800 1,503,896 Algeria Angola 15,060,576 300,000 1,212,002 Bangladesh 1,224,000 265,253 4,383,060 300,000 115,651,300 Belize 10,000 15,200 50,760 Benin 103,000 214,400 125,600 52,000 Bhutan 1,584,000 Bolivia 10,000 78,500 60,000 12,240 Burkina Faso 7,301,000 416,984 1,161,500 41,0

120、00 4,800 Burundi 130,000 1,080,000 26,050 343,160 Cabo Verde 2,880,000 60,000 267,120 Cambodia 6,724,800 55,780 750,000 50,000 11,455,614 Cameroon 24,774,470 29,780 40,000 41,100 80,640 Central African Republic 738 94,900 13,000 1,615,008 Chad 1,008,000 153,366 379,800 20,000 226,080 Comoros 1,180,8

121、00 500 Congo Dem Rep 46,256,800 907,864 3,128,810 211,384 2,297,938 Cote dIvoire 25,732,600 180,376 692,050 33,000 2,906,090 Djibouti 288,000 218,160 El Salvador 3,049,000 160,000 84,672 Eritrea 17,300 100,000 10,800 Ethiopia 11,628,720 1,558,934 8,006,045 55,863 9,009,906 Gambia 2,548,800 69,984 14

122、0,000 105,840 Ghana 390,383 1,596,700 31,653 4,097,860 Guinea 49,433,000 666,600 38,000 287,440 Guinea-Bissau 7,557,900 22,500 3,000 221,436 Haiti 68,804,640 10,000 2,691,800 670,896 Honduras 10,728,000 144 45,000 1,200,000 India 814,796 38,100 Indonesia 5,000 1,093,300 Kenya 38,478,000 373,320 80,0

123、00 448,930 3,613,720 Kiribati Kyrgyz Republic 198,000 Lao PDR 1,490,400 256,000 2,857,608 Lesotho 1,728,000 2,016 65,800 117,900 Liberia 13,440,000 9,800 75,000 12,500 Madagascar 308,616 5,184,400 90,500 1,599,120 Malawi 119,369,000 670,252 6,569,700 2,571,300 28APPENDICESExhibit A.3:83 LMICs-Contra

124、ceptive market volumes by method,2019 CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsMali 25,216,560 293,636 256,200 29,000 682,560 Mauritania 5,000 18,580 46,200 813,960 Mongolia 180,000 13,800 103,260 103,000 285,600 Morocco Mozambique 69,433,000 202,108 4,086,200 31,150 4,5

125、18,240 Myanmar 26,785,000 80,100 1,425,000 30,000 16,447,915 Nepal 13,999,870 224,200 349,800 2,407,144 Nicaragua 5,484 Niger 444,000 116,248 100,000 1,416,762 Nigeria 60,693,400 1,217,772 3,450,800 329,216 1,457,740 Pakistan 3,749,600 242,600 204,400 1,226,500 40,320 Papua New Guinea 2,997,800 145,

126、000 572,400 479,643 Philippines 2,390,400 200,000 29,808 Rwanda 15,346,000 213,185 441,000 27,000 956,160 Samoa Sao Tome and Principe 1,260,376 800 19,000 100,080 Senegal 12,218,000 142,056 466,000 72,000 986,580 Sierra Leone 5,589,400 284,900 276,000 57,500 468,720 Solomon Islands Somalia 28,800 45

127、,000 810,000 South Sudan 50,000 350,000 1,004,400 Sri Lanka 4,913 100,508 2,119,680 Sudan 26,800 146,400 6,472,122 Tajikistan 9,572,398 166,000 717,768 Tanzania 30,880,356 421,154 3,895,300 174,590 4,488,591 Timor-Leste 725,760 10,000 220,000 340,704 Togo 26,079,160 79,600 274,400 600,192 Tunisia 5,

128、000 Uganda 147,135,800 414,360 3,655,140 161,500 436,968 Ukraine 21,382,200 Uzbekistan 6,652,800 570,000 1,730,000 760,002 Vanuatu Vietnam 11,000 490,900 476,950 Western Sahara Yemen 1,449,600 97,708 498,600 128,100 12,694,226 Zambia 60,015,740 94,934 2,884,600 14,800 4,628,694 Congo 26,300 19,800 1

129、91,405 9,540 DPR Korea 74,880 29Exhibit A.3:83 LMICs-Contraceptive market volumes by method,2019 CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsEgypt 11,224,800 333,164 490,200 Eswatini 22,008,000 82,999 4,500 Iran Micronesia State of Palestine 1,761,120 Syria 1,895,040 Zimbab

130、we 140,329,440 186,600 758,000 48,500 16,751,896 Other LMIC Shipments 5,955,160 456,500 6,291,200 341,900 12,749,040 Total Volumes 1,194,052,999 11,520,687 70,692,064 9,215,687 260,085,841 Sources:1 Historical Supplier-Reported Shipment Data;2 RH Viz Shipment Data,retrieved August 2022.APPENDICES30E

131、xhibit A.4:83 LMICs-Contraceptive market volumes by method,2020CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsAfghanistan 8,783,160 42,200 280,974 504,954 Algeria Angola 51,788,140 500,000 1,568,374 Bangladesh 943,200 20,000 14,867,040 2,500 163,162,360 Belize Benin 15,000 10,

132、000 762,000 20,000 441,504 Bhutan Bolivia 11,000 36,000 50,000 9,500 14,400 Burkina Faso 26,343,300 236,448 3,041,050 98,400 1,565,376 Burundi 18,439,200 193,100 1,176,000 336,492 Cabo Verde 13,512,100 5,000 80,000 310,356 Cambodia 124,272 43,160 400,000 4,406,662 Cameroon 15,854,400 123,340 1,034,4

133、00 4,500 603,900 Central African Republic 6,480,000 63,900 214,600 171,360 Chad 9,273,800 560,000 342,120 Comoros 500 Congo Dem Rep 77,059,680 1,194,128 966,200 122,000 3,090,000 Cote dIvoire 8,642,000 198,000 987,000 28,500 4,758,577 Djibouti 250,880 200 39,600 El Salvador 10,127,200 50,000 467,280

134、 Eritrea 14,500 4,000 162,000 Ethiopia 1,968,240 1,290,093 5,458,646 16,600 2,570,348 Gambia 29,000 193,300 150,192 Ghana 11,930,400 316,176 2,059,300 98,850 5,960,232 Guinea 291,000 136,800 59,200 51,300 Guinea-Bissau 3,024,000 53,400 232,600 800,460 Haiti 21,600,000 11,600 Honduras 16,999,200 49,4

135、56 690,900 India 107,884 24,960 Indonesia 1,047,270 Kenya 23,732,800 1,527,332 1,360,048 400,750 3,319,772 Kiribati Kyrgyz Republic 300 Lao PDR 526,000 1,600,488 Lesotho 4,378,600 2,900 129,800 1,500 660,780 Liberia 15,774,000 81,700 363,000 780,120 Madagascar 11,334,760 485,114 3,635,300 216,000 5,

136、438,960 Malawi 59,538,600 386,442 4,810,000 11,400 1,400,232 APPENDICES31Exhibit A.4:83 LMICs-Contraceptive market volumes by method,2020CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsMali 2,954,200 297,950 937,300 31,000 30,960 Mauritania 3,300 175,600 385,344 Mongolia 280,80

137、0 11,900 75,000 14,400 495,000 Morocco Mozambique 106,529,230 124,700 1,136,900 2,654,220 Myanmar 17,952,400 52,232 3,463,620 3,500 13,207,812 Nepal 11,695,970 72,500 10,000 365,220 Nicaragua 705,600 6,600 6,000 Niger 17,894,740 96,256 389,860 51,300 4,400,010 Nigeria 76,046,500 1,491,608 4,234,600

138、722,299 2,993,913 Pakistan 30,096,000 95,200 192,112 443,520 Papua New Guinea 4,266,600 31,000 Philippines 403,364 30,725 Rwanda 31,076,000 46,728 58,200 8,000 1,224,009 Samoa Sao Tome and Principe 200 17,400 2,700 Senegal 9,345,000 125,000 1,007,072 28,760 1,157,409 Sierra Leone 2,932,688 516,100 1

139、,515,000 29,000 1,741,998 Solomon Islands 10,000 Somalia 8,400 77,001 South Sudan 8,640,000 250,000 2,500 1,531,920 Sri Lanka 40,064 30,000 50,000 2,119,680 Sudan 4,320,000 59,944 2,500 6,000 4,651,020 Tajikistan 5,889,600 160,000 496,944 Tanzania 19,067,140 801,040 2,475,000 192,399 6,231,664 Timor

140、-Leste 4,068,000 19,000 118,000 126,000 Togo 20,843,800 15,540 316,400 46,000 Tunisia Uganda 84,725,600 878,680 2,341,900 138,000 1,915,410 Ukraine Uzbekistan 6,854,400 279,400 830,000 Vanuatu 40,000 Vietnam 3,888,000 33,000 146,440 169,350 Western Sahara Yemen 504,000 67,900 70,000 200,000 5,177,94

141、0 Zambia 99,441,200 406,532 3,228,400 118,800 5,095,576 Congo 625 21,300 148,600 12,600 DPR Korea APPENDICES32Exhibit A.4:83 LMICs-Contraceptive market volumes by method,2020CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsEgypt 1,000 53,000 1,387,600 180,030 Eswatini 9,900 Iran

142、 Micronesia State of Palestine 3,335,042 Syria 5,927,900 Zimbabwe 57,873,000 264,444 2,555,400 69,000 13,756,208 Other LMIC Shipments 4,111,600 1,126,600 14,319,600 193,560 21,995,237 Total Volumes 1,059,494,942 13,649,296 84,863,476 6,088,263 297,002,374 APPENDICESSources:1 Historical Supplier-Repo

143、rted Shipment Data;2 RH Viz Shipment Data,retrieved August 2022.33Exhibit A.5:83 LMICs-Contraceptive market volumes by method,2021CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsAfghanistan 52,000 605,200 142,700 3,670,668 Algeria Angola 385,000 600,000 Bangladesh 6,220,800 845

144、,885 3,926,560 34,500 178,895,520 Belize 122,400 51,192 Benin 6,000,000 20,000 10,000 989,280 Bhutan Bolivia 30,000 291,114 Burkina Faso 43,021,480 894,124 520,000 5,993,475 Burundi 173,200 161,550 30,000 424,800 Cabo Verde 10,000 150,000 318,528 Cambodia 52,040 55,000 5,957,011 Cameroon 880,020 79,

145、880 30,000 95,040 Central African Republic 7,200,000 317,472 Chad 5,784,480 125,976 300,000 296,640 Comoros 30,240 Congo Dem Rep 196,001 781,100 2,187,100 6,000 1,274,037 Cote dIvoire 8,260,620 150,880 524,600 29,900 6,698,447 Djibouti 561,024 3,000 9,600 El Salvador 714,096 277,920 Eritrea 35,200 9

146、8,400 5,000 171,900 Ethiopia 3,041,400 1,716,725 953,200 488,000 2,253,150 Gambia 2,200,610 3,000 189,000 671,310 Ghana 30,495,200 193,192 2,715,600 53,000 4,329,200 Guinea 28,223,800 100,000 300,000 22,000 20,700 Guinea-Bissau 7,404,190 20,000 3,600 11,280 Haiti 23,000 410,000 268,128 Honduras 43,6

147、82,360 26,056 692,200 29,490 651,330 India 574,270 Indonesia 51,132 335,800 Kenya 706,740 312,800 3,575 300,240 Kiribati Kyrgyz Republic 1,814,400 Lao PDR 222,000 20,700 Lesotho 1,640,040 3,795 252,600 2,500 763,434 Liberia 7,407,000 41,300 177,200 4,000 693,504 Madagascar 793,800 194,184 1,510,000

148、9,500 4,416,048 Malawi 145,520,300 358,416 2,008,000 20,100 218,880 APPENDICES34Exhibit A.5:83 LMICs-Contraceptive market volumes by method,2021CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsMali 46,485,520 183,505 778,800 17,000 437,040 Mauritania 3,499,200 19,600 65,400 51,5

149、00 355,338 Mongolia 187,200 6,000 41,250 49,000 286,000 Morocco Mozambique 78,397,400 386,696 2,279,000 8,750 1,967,202 Myanmar 37,621,290 24,640 269,380 9,473,857 Nepal 9,252,000 130,000 2,470,000 4,975,504 Nicaragua 4,896,000 600 85,000 276,066 Niger 151,000 838,000 50,500 1,774,224 Nigeria 102,32

150、8,200 1,714,504 2,958,775 81,235 1,047,191 Pakistan 18,892,800 246,400 425,000 260,360 1,450,080 Papua New Guinea 2,535,120 25,000 404,000 391,878 Philippines 6,451,200 502,917 9,600 Rwanda 21,467,740 130,016 476,400 2,520 584,424 Samoa Sao Tome and Principe 346,320 500 24,000 126,720 Senegal 5,505,

151、000 130,084 1,845,200 58,500 813,600 Sierra Leone 13,489,920 349,500 974,900 1,189,548 Solomon Islands 10,000 Somalia 504,000 18,000 43,000 20,000 194,292 South Sudan 120,000 41,100 150,000 1,000 Sri Lanka 1,668,960 104,032 372,800 33,000 Sudan 7,552,800 77,400 150,625 35,500 100,080 Tajikistan 10,1

152、48,400 7,500 Tanzania 605,000 518,707 1,340,000 25,500 6,057,526 Timor-Leste 36,000 122,000 139,680 Togo 12,816,000 76,700 60,000 48,396 Tunisia 1,512,000 80,750 Uganda 420,326,400 463,564 3,640,200 68,400 2,267,860 Ukraine 30 Uzbekistan 534,360 Vanuatu Vietnam 40,000 Western Sahara Yemen 42,700 160

153、,000 Zambia 72,474,000 430,900 2,903,600 178,945 3,628,512 Congo 8,640,000 5,100 6,600 406,275 30,600 DPR Korea APPENDICES35Exhibit A.5:83 LMICs-Contraceptive market volumes by method,2021CountryCondoms-Male&FemaleImplantsInjectablesIUDs-Copper&HormonalOralsEgypt 365,090 Eswatini 4,208 72,000 Iran M

154、icronesia State of Palestine 1,000 Syria 50,000 Zimbabwe 50,475,000 173,324 510,000 15,000 3,813,984 Other LMIC Shipments 2,216,000 422,000 15,751,320 146,550 8,160,126 Total Volumes 1,291,982,491 13,528,112 57,896,060 4,221,010 269,960,916 Sources:1 Historical Supplier-Reported Shipment Data;2 RH V

155、iz Shipment Data,retrieved August 2022.APPENDICES36APPENDIX B DATA SOURCESIn developing this reports market analyses,a variety of data sources from partner organizations that provide family planning market data at the global level were reviewed.These databases were assessed based on available metric

156、s,coverage of countries,frequency of updates,and ease of access to identify the most appropriate sources for sustainable analyses,that will be updated as new data becomes available.The following provides an overview of the data sources this report relied upon for market analyses:FP2020 Global Market

157、s Visibility ProjectIn early 2014,CHAI,in partnership with RHSC and the FP2020 Market Dynamics Working Group,launched the Global Markets Visibility Project to help various donors,suppliers,and partners improve their understanding of the current market size and trends for key contraceptive markets.In

158、 the past,CHAI collected historical shipment data by product and country from suppliers for each of the 69 FP2020 focus countries and this year has updated the market reports geographic scope to include the 83 LMICs.For the reports published in 2015,2016,2017,and 2018,CHAI partnered with Concept Fou

159、ndation to collect and aggregate shipment data from participating members of the former RHSC Generic Manufacturers for Reproductive Health Caucus(GEMs).For the subsequent reports,CHAI has collected shipment data directly from the former GEMs suppliers.To date,the Global Markets Visibility Project ha

160、s collected historical shipment data that covers global procurer sales(USAID and UNFPA),MOH tender volumes and SMO purchases from 17 manufacturers across five family planning product categories.The main analyses and data reflected in this report in the Supplier Shipment Analysis and associated Appen

161、dices are based on the supplier shipment data collected through this project.U.S.Agency for International Development(USAID)USAID has provided commodities for family planning and reproductive health activities since the mid-1960s.The Overview of Contraceptive and Condom Shipments report is an annual

162、 publication that summarizes contraceptive and condom shipments sponsored by USAID,by value and unit.For the purposes of this years Family Planning Market Reports Global Procurer Spend Analysis,the FY2017 through FY2021 reports were accessed and used to analyze USAIDs spend on contraceptives in LMIC

163、s,excluding male and female condoms,over the period.Values are inclusive of commodity and freight costs and are reported based on the USAID fiscal year which ends on September 30.32 Previous versions of this report utilized the publicly available Reproductive Health Interchange(RHI)dataset.On Septem

164、ber 21,2020,the RHI interface was replaced by RH Viz;accordingly,this report has transitioned to using the RH Viz database.The United Nations Population Fund(UNFPA)Procurement Services Branch(PSB)Procurement DataUNFPA is the lead agency within the United Nations system for the procurement of reprodu

165、ctive health commodities and has been procuring reproductive health supplies for LMICs for over 40 years.For the purposes of this years Family Planning Market Reports Global Procurer Spend Analysis,CHAI worked with UNFPA PSB to determine the value of the contraceptive procurement conducted by UNFPA

166、from 2017 to 2021 for LMICs.Values are inclusive of commodity cost and exclude services such as freight,sampling,inspection,and testing and are reported based on the calendar year.Reproductive Health Supplies Visualized(RH Viz)32The RH Viz database provides visibility into contraceptive shipments vo

167、lumes via a series of public-facing dashboards.RH Viz leverages both historical procurement shipment data(from 2008-2016),as well as live procurer shipment data from the Global FP VAN(from 2017 forward).Data provided from the Global FP VAN(in RH Viz)currently reflects shipments from and reported by

168、USAID and UNFPA.RH Viz is used as a comparison point for the supplier dataset for a high-level understanding of supplier shipment data coverage,as well as for male condom data.APPENDICES37APPENDIX C ESTIMATING THE VALUE OF THE PUBLIC-SECTOR MARKETThe value of the public-sector market was calculated

169、using the most comprehensive available data sources:historical supplier-reported shipment data and RH Viz shipment data.Shipment data is recorded in the following units:Exhibit C.1:Unit of measurementMethodUnit of MeasureCondoms FemalePieceCondoms MalePieceImplantsSetInjectablesVialIUDs CopperPieceI

170、UDs-HormonalPieceOrals CombinedCycleOrals Progestin OnlyCycleOrals EmergencyDosesAPPENDICES38Historical Supplier-Reported DataThis years market report includes historical supplier-reported shipment data from 17 manufacturers Bayer,Cipla,Corporate Channels,CR Zizhu,Cupid,Female Health Company,Incepta

171、,Medicines360,Organon&Co.,Pfizer,Pregna,PT Tunggal,Renata,Shanghai Dahua,SMB,Techno Drugs,and Viatris(Mylan).Collectively,the total volumes cover global procurer sales(USAID and UNFPA),MOH tenders and SMO purchases across five family planning product categories.33 SUPPLIERS HAVE CUMULATIVELY SHIPPED

172、 88 MILLION FEMALE CONDOMS,57 MILLION IMPLANTS,354 MILLION INJECTABLES,37 MILLION COPPER IUDS,0.2 MILLION HORMONAL IUDS,1,223 MILLION ORALS(COMBINED&PROGESTIN ONLY),AND 53 MILLION EMERGENCY CONTRACEPTIVES FROM 2017 TO 2021.It is important to note that there were several shipments to procurer(USAID,U

173、NFPA,SMOs)warehouses in non-LMICs,such as Belgium,Denmark,Finland,France,Germany,Netherlands,Switzerland,and UK.Although these volumes were initially shipped to non-LMICs,33 Total shipment of oral contraceptives includes combined,progestin-only,and emergency oral contraceptives.these shipments were

174、likely to go onto the 83 LMICs.As a result,these non-LMIC volumes were included in the total shipments to the 83 LMICs after it was confirmed with suppliers that the specific non-LMIC volumes were associated with global procurer purchases.CHAI analyzed the aggregated historical supplier-reported shi

175、pment data to confirm that coverage across the public-sector product markets was greater relative to RH Viz shipment data for the 83 LMICs.The aim of collecting historical volumes of all global procurer purchases,SMO purchases and MOH tenders directly from suppliers was to address data gaps observed

176、 in publicly available shipment data which only capture a subset of procurers who chose to submit historical procurement data.Furthermore,although some countries report national procurements,many national procurements are not reported in publicly available databases.The cumulative total from 2017 to

177、 2021 for historical supplier-reported shipment volumes to the 83 LMICs and procurer warehouses is greater than RH Viz in every method(Exhibit C.4).Exhibit C.2:Global Markets Visibility Project participants and productsManufacturerCondoms-FemaleImplantsInjectablesIUDsOralsBayerCiplaCorporate Channel

178、sCR ZizhuCupidFemale Health CompanyInceptaMedicines360Organon&Co.PfizerPregnaPt TunggalRenata Shanghai DahuaSMBTechno DrugsViatris(Mylan)APPENDICES39Exhibit C.4:Supplier-reported shipment volumes as a percentage of RH Viz-reported volumes by method,2017-2021Method200202021Cumulative Total

179、Condoms-Female136%75%141%108%105%113%Implants167%115%143%143%131%137%Injectables160%179%129%136%102%138%IUDs-Copper&Hormonal235%388%382%317%272%330%Orals-Combined&Progestin Only442%303%359%257%332%299%Orals-Emergency1529%537%675%593%394%576%APPENDICESExhibit C.3:Supplier-reported shipment volumes to

180、 83 LMICs by method,2017-2021Method200202021Cumulative TotalCondoms Female22M13M22M18M13M88MImplants8M10M12M14M14M57MInjectables59M82M71M85M58M354MIUDs-copper5M12M9M6M4M37MIUDs-hormonal0.02M0.02M0.03M0.01M0.12M0.2MOrals-Combined&Progestin Only218M213M251M283M257M1223MOrals-Emergency8M9M9M

181、14M13M53MNote:Cumulative totals calculated using actual,rather than rounded numbers.Sources:1 Historical Supplier-Reported Shipment Data;2 RH Viz Shipment Data,retrieved August 202240Male Condom MarketRH Viz shipment data for male condoms was used to capture a more comprehensive view of the public-s

182、ector family planning market for the 83 LMICs.The report used RH Viz shipment data from 2017 to 2021 and included all male condom shipment volumes to the 83 LMICsas well as volumes associated with procurer warehouses in non-LMICs.34 The supplier-reported volumes for female condoms,implants,injectabl

183、es,IUDs,and orals,together with RH Viz shipment volumes for male condoms,represent the estimated public-sector market from 2017 to 2021.34 Total yearly volumes are based on the year that the product was shipped.Exhibit C.5:RH Viz male condoms shipment volumes,2017-2021Method200202021Condo

184、ms Male 0.65B 1.21B 1.17B 1.04B 1.28B Sources:1 RH Viz Shipment Data,retrieved August 2022APPENDICES41Total Public-Sector Market in Terms of CYPsAll shipment volumes were translated to CYPs shipped by dividing shipment volumes by each methods corresponding CYP factor.All shipment volumes were divide

185、d by the corresponding CYP factor published by USAID35.CYP factors calculate the estimated protection provided by different contraceptive methods.Because methods may have different CYPs associated with several different sub-types of that method(e.g.,there are different CYP factors for three-and five

186、-year implants)the corresponding CYP of the method sub-type is used.The following exhibit shows the conversion factors used to translate volumes to CYPs.35 USAID refreshed its CYP conversation factors in 2022;these updates have been incorporated into the Family Planning Market Report.USAID,“Couple-Y

187、ears of Protection(CYP)”,available at https:/www.usaid.gov/global-health/health-areas/family-planning/couple-years-protection-cyp.Sources:1 USAID,“Couple-Years of Protection(CYP),”January 2022.APPENDICESExhibit C.6:Volumes to CYPs shipped conversion factors,20172021MethodPer Couple-Years of Protecti

188、on(CYP)Condoms-Female120Condoms-Male120Implants-3 Year0.4Implants-5 Year0.26Injectables-1 month13Injectables-2 month6Injectables-3 month4IUDs-copper0.22IUDs-hormonal0.21Orals Combined 15Orals Progestin Only12Orals Emergency2042Value of the Total Public-Sector MarketThe total value of contraceptives

189、was calculated by applying average unit prices to total shipment volumes.Although different prices exist across products and markets,the report estimated implied spend using UNFPAs Contraceptive Price Indicator,given the Contraceptive Price Indicator is publicly available and consistently updated.36

190、 A publicly available price for hormonal IUDs was published for the first time in the UNFPA Contraceptive Price Indicator in 2021,hence this price has been used for the calculation of hormonal IUDs market value for 2017-2020 as well.Finally,the Implant Access Program price of$8.50 was applied to imp

191、lant volumes from 2017 to 2018.In 2019-2021,the average implant price on the UNFPA Contraceptive Price Indicator varied from$8.50accordingly,UNFPAs listed price was used in market value calculations for 2019,2020,and 2021.The average price only includes the cost of the product and does not account f

192、or additional costs associated with procurement such as testing,insurance,and shipping costs.36 UNFPA,“UNFPA Contraceptive Price IndicatorYear 2021”,available at https:/www.unfpa.org/sites/default/files/resource-pdf/Contraceptive%20Price%20Indicator%202021.pdf,UNFPA,“UNFPA Contraceptive Price Indica

193、torYear 2020”,available at https:/www.unfpa.org/sites/default/files/resource-pdf/UNFPA_Contraceptives_Price_ Indicator_2020.pdf,UNFPA,“UNFPA Contraceptive Price IndicatorYear 2019”,available at https:/www.unfpa.org/sites/default/files/resource-pdf/UNFPA_Contraceptive_Price_Indicators_2019_V2_-_EXTER

194、NAL.pdf,UNFPA,“UNFPA Contraceptive Price Indicator Year 2018”,available at https:/www.unfpa.org/sites/default/files/resource-pdf/UNFPA_Contraceptive_Price_Indicators_2018_.pdf,UNFPA,“UNFPA Contraceptive Price Indicator Year 2017”,available at https:/www.unfpa.org/resources/contraceptive-price-indica

195、tor-year-2017.Notes:1 For 2017-2018 implants,the Implant Access Program price is used;2 For 2017-2021,the 2021 publicly available price for hormonal IUDs is used;3 Otherwise,the price range and unit prices in each year are based on UNFPAs Contraceptive Price Indicator.Sources:1 UNFPA Contraceptive P

196、rice Indicator,2017 to 2021;2 IAP Implant Prices.APPENDICESExhibit C.7:Average unit priceMethodPrice Range200202021MinimumMaximumUnit PriceUnit PriceUnit PriceUnit PriceUnit PriceCondoms-Female$0.43$0.47$0.46$0.47$0.44$0.43$0.44 Condoms Male$0.02$0.02$0.02$0.02$0.02$0.02$0.02 Implants$8.2

197、6$8.68$8.50$8.50$8.37$8.26$8.68 Injectables$0.77$0.81$0.79$0.81$0.77$0.81$0.81 IUDs-Copper$0.30$0.43$0.31$0.30$0.31$0.37$0.43 IUDs-Hormonal$10.84$10.84$10.84$10.84$10.84$10.84$10.84 Orals Combined$0.21$0.27$0.27$0.24$0.23$0.23$0.21 Orals Progestin Only$0.28$0.32$0.32$0.29$0.29$0.30$0.28 Orals-Emerge

198、ncy$0.25$0.40$0.26$0.28$0.40$0.26$0.25 43APPENDIX D ESTIMATING TOTAL LMIC GLOBAL PROCURER-SPEND VOLUMES To protect customer confidentiality,suppliers were not asked to disclose customer information associated with shipment volumes.CHAI and RHSC use information from USAID,GHSC-PSM,and UNFPA to unders

199、tand global procurer spend by the two major global procurers of family planning commodities.For more information on each of these data sources,refer to Appendix B.Going forward,CHAI and RHSC will continue to work closely with the two major global procurers of family planning commodities to ensure th

200、e data provided is the most accurate and accessible for the purposes of this report.APPENDICES44APPENDIX E ADDITIONAL MARKET VISIBILITYThis report has historically included supplementary research and analysis using publicly available data sources in three large markets:Bangladesh,India,and Indonesia

201、37.In this section,the analysis is refreshed with the latest data for Bangladesh and India.Publicly available data on government procurement has been limited in Indonesia in recent years,so Indonesia has been removed for now from the market visibility analysis.Given the limitations of publicly avail

202、able data sources,this report cannot confirm that these market visibility analyses represent comprehensive coverage of the public-sector markets in India and Bangladesh.Rather,the data is meant to be used as initial view into domestic procurement in these markets,that may not be fully covered by the

203、 suppliers participating in this report.BangladeshThe Bangladesh Ministry of Health and Family Welfare(MOHFW)procured38 7 million CYPs for the 2021 calendar year,as compared to 13 million CYPs for the 2020 calendar year,12 million CYPs for the 2019 calendar year,17 million CYPs for the 2018 calendar

204、 year,and 3 million CYPs for the 2017 calendar year.Procurement contracts in 2021 were awarded primarily to regional and local suppliers,including(but not limited to):Essential Drugs Co.,Khulna Essential,M/S,Renata Ltd.,Popular Pharmaceuticals Ltd39,and Techno Drugs.Although data from only a subset

205、of these manufacturers is included in the supplier shipment data,suppliers represented in the Family Planning Market Report comprised a larger proportion of reported MOHFW volumes in 2021 than in 202040.By applying the same prices41 used for 2021 supplier shipment analyses to the volumes from the Ba

206、ngladesh MOHFW procurement data,the implied value from Bangladeshs procurement contracts is estimated to be$21 million for 2021,as compared to the$13 million implied by the 2021 supplier shipment data.Although contraceptive procurement has fluctuated in Bangladesh,consumption has remained stable.A r

207、eview of Bangladeshs supply chain reports42 revealed that consumption of contraceptive commodities has been fairly consistent between 9.5 to 12.6 million CYPsfrom 2017 to 2021.This analysis relies on data from the Government of Bangladeshs Ministry of Health and Family Welfare(MOHFW)43 for 2017,2018

208、,2019,2020,and 2021.4437 Bangladesh and India accounted for a large proportion of the gap between FP2030-reported users of product-based methods and users implied by the shipment data based on country-specific comparisons(per 2016 analysis,when market visibility analysis was added to the Family Plan

209、ning Market Report).Note:Indonesia also accounts for a notable proportion of the gap between FP2030-reported users of product-based methods and users implied by the shipment data but is currently excluded from the market visibility analysis given limited publicly available data on procurement in rec

210、ent years.38 Note the Bangladesh MOHFW records procurement in terms of the date received for shipments,rather than date shipped.39 In 2017,Incepta supplied the Ministry of Health and Family Welfare(MOHFW)with injectables via Popular Pharmaceuticals Ltd.Source:Incepta Pharmaceuticals.40 Manufacturers

211、 from Bangladesh participating in this report include Techno Drugs,Popular Pharmaceuticals Ltd(via Incepta Pharmaceuticals),and M/S Renata Ltd.41 To estimate the market value in Bangladesh and India,the report applies the same pricing assumptions used for supplier shipment analyses(from the UNFPA Co

212、ntraceptive Price Indicator)throughout the market visibility appendix.Actual pricing may differ in these markets given the different suppliers and pricing parameters at play.However,the UNFPA prices have been applied to maintain publicly available,consistently updated pricing assumptions throughout

213、the report.42 Consumption CYP is calculated using data published by the Bangladesh MOHFW consumption trend tracker and the USAID CYP factors.Bangladesh consumption data available here:https:/scmpbd.org/index.php/lmis-report/month-wise-consumption 43 Government of Bangladesh,Ministry of Health and Fa

214、mily Welfare,“MOHFW Supply Chain Management Portal National Receive Details;Product Group:Contraceptive;Product Name:ALL;Warehouse;ALL”available at:https:/scmpbd.org/index.php/wims-reports/national-receive-details44 The fiscal year for Bangladesh runs from July 1 to June 30 but,for the purposes of t

215、his analysis,monthly procurement data was summed for each calendar year for 2017-2021.APPENDICES45Exhibit E.1:MOHFW supply chain contraceptive shipment receipt details (publicly available volumes data)Product NameSupplier Name200202021CONDOMDirect Relief-1,584,000-CONDOMESSENTIAL DRUGS CO

216、.LTD.-56,854,80011,600,80072,163,60091,088,400CONDOMKHULNA ESSENTIAL LATEX PLANT(KELP)-62,158,80095,894,00044,388,40036,794,400CONDOMUNFPA1,195,20010,080,000-ECP(2 TAB/PACK)M/S,RENATA LTD.-100,000100,000100,000100,000IMPLANT(2 ROD)TECHNO DRUGS Ltd-385,000429,054-575,000IMPLANT(2 ROD)USAID35,000-IMPL

217、ANT(SINGLE ROD)JAMES INTERNATIONAL2,880-IMPLANT(SINGLE ROD)Merck Sharp&Dohme B.V(MSD B.V.).3,000-IMPLANT(SINGLE ROD)MSD-NV Organon,Organon(India)Private Ltd.199,980-IMPLANT(SINGLE ROD)UNFPA-200,0005,000-INJECTABLES(DMPA-IM)Popular Pharmaceuticals Ltd.1,000,0001,000,000-INJECTABLES(DMPA-IM)TECHNO DRU

218、GS Ltd5,000,00018,250,0008,230,00015,250,00014,000,000INJECTABLES(DMPA-IM)UNFPA299,997-INJECTABLES(DMPA-IM)USAID1,000,000914,800-IUD(CT-380A)IPAS Bangladesh-9,500-IUD(CT-380A)MARIE STOPES CLINIC65,00056,000-IUD(CT-380A)SARBAN INTERNATIONAL LTD.-300,000-IUD(CT-380A)SMB Corporation of India-450,000-IU

219、D(CT-380A)UNFPA-200,000-IUD(CT-380A)Pathfinder-300ORAL CONTRACEPTIVE PILL(SHUKHI)M/S,RENATA LTD.-54,800,125110,000,00150,500,00043,940,000ORAL CONTRACEPTIVE PILL(SHUKHI)Popular Pharmaceuticals Ltd.-16,700,000-12,500,00011,230,000ORAL CONTRACEPTIVE PILL(SHUKHI)TECHNO DRUGS Ltd-16,700,000-38,000,00032

220、,800,000ORAL PILL APONM/S,RENATA LTD.750,0004,000,0001,000,0003,500,0009,000,000APPENDICESSource:Bangladesh MOHFW,Supply Chain Management Portal,2022.46IndiaBased on Indias Ministry of Health and Family Welfare(MOHFW)45 Annual Report for the 2021-2022 fiscal year46,CYPs procured from product-based m

221、ethods47 totaled 18 million.This number is lower than the 2017-2018 to 2020-2021 fiscal year average of 44 million CYPs procured annually.Weekly oral contraceptive procurement volumes continued to increase further in 2021-2022 from 2020-2021(volumes procured increased by 22 percent in 2021-2022 from

222、 2020-2021 compared to an increase of 1 percent in 2020-2021 from 2019-2020,at the time of reporting).Copper IUDs continued to comprise the majority of CYPs provided in the MOHFW basket in 2021-2022;a total of 12 million out of 18 million CYPs provided were from copper IUDs.Although the MOHFW report

223、s annual shipment volumes based on a fiscal year schedule instead of the calendar years used in this report,for simplicity the same prices(in Exhibit C.7)were used to estimate the implied annual market value for supplier shipment and MOHFW procurement volumes.These calculations show MOHFW procuremen

224、t values of approximately$13 million in the 2021-2022 fiscal year and$37 million in the 2020-2021 fiscal year,compared to the$1.8 million and$1.6 million implied by the 2021 and 2020 supplier shipment data.45 Government of India,Ministry of Health and Family Welfare,“Annual Report of Department of H

225、ealth&Family Welfare for the year of 2021-22”,“Annual Report of Department of Health&Family Welfare for the year of 2020-21”,“Annual Report of Department of Health&Family Welfare for the year of 2019-20”,“Annual Report of Department of Health&Family Welfare for the year of 2018-19”,“Annual Report of

226、 Department of Health&Family Welfare for the year of 2017-18”,available at:https:/main.mohfw.gov.in/documents/publication/publication-archives.46 The fiscal year for India runs from April 1 to March 31.Accordingly,all values from the most recent year are provisional;not all data has been reported at

227、 the time of publishing(for MOHFW reports).47 Only modern contraceptive methods from Indias MOHFW reports,including condoms,injectables,IUDs,and oral contraceptives are included in this analysis.APPENDICESExhibit E.2:Annual reports of Department of Health&Family Welfare(includes fiscal years 2017-18

228、 to 2021-22)Exhibit E.2.1:Quantities supplied to States/UTs(publicly-available data)Contraceptives--212021-22*Condoms(in million pieces)526.840378.12397.1205.01Oral Pills(in lakh cycles)275.25394.37591.64427.63184.38Copper IUDs(in lakh pieces)22.6288.587.7373.7927.75ECP(in la

229、kh packs)50.44128195.74131.722.47Centchroman Contraceptive Pill(Lakh Strips)23.99170.27116.66117.69143.16Injectable Contraceptive(Lakh Doses)27031.529.270Exhibit E.2.2:Social marketing sales of contraceptives(publicly-available data)Contraceptives--212021-22*Condoms(Million p

230、ieces)483.21459.51507.46244.31126.11Oral Pills(Social Marketing)(lakh cycles)205.31159.19147.1195.984.56SAHELI(in Lakh tablets)321.7677.52000*Figures are Provisional47APPENDIX F KEY TERMS AND DEFINITIONSCYPCouple Years of Protection(CYP)is the estimated protection provided by contraceptive methods d

231、uring a one-year period(e.g.,120 condoms provide a couple protection for one year).CYP mixCYP mix refers to the percentage distribution of CYPs shipped by method.ValueValue refers to the supplier-reported shipment volume multiplied by the estimated price(from the UNFPA Contraceptive Price Indicator)

232、for specific years.Market ShareMarket share is the percentage of total value(or volumes,if applicable)of shipment volumes in a market captured by a certain contraceptive method.Shipment VolumesShipment volumes refers to the amount of a particular contraceptive method that has been transported.Total

233、Public-Sector MarketThe total public-sector market is based on volumes purchased by global procurers,MOH-or government-affiliated procurers and SMOs based on RH Viz data(male condoms)and historical supplier-reported shipment data(female condoms,implants,injectables,IUDs copper and hormonal,and oral

234、contraceptives)for the 83 low-and lower-middle income countries as per the World Bank income classification in 2020.This is in line with the new global partnership and measurement structure for the sexual and reproductive health(SRH)community announced by FP2030 in 2021.Further information on the LM

235、ICs for which FP2030 will report data is available in the“FP2030 Measurement Report 2021”.Note that the FP2030 report includes 82 LMICs,which is one less than the 83 countries in-scope for the Family Planning Market Report.Due in part to data challenges,FP2030 is not presently reporting data on West

236、ern Sahara(which was formerly among the 69 FP2020 focus countries.)After consultation with FP2030,however,CHAI and the RHSC have kept Western Sahara in scope for the FP Market Report,for a total of 83 in-scope LMICs.APPENDICES48APPENDIX G ACRONYMSCHAICLINTON HEALTH ACCESS INITIATIVECYPCOUPLE-YEARS O

237、F PROTECTIONFPFAMILY PLANNINGGEMSGENERIC MANUFACTURERS FOR REPRODUCTIVE HEALTHIUDINTRA-UTERINE DEVICELARC LONG-ACTING REVERSIBLE CONTRACEPTIVESLMICs LOW-AND LOWER-MIDDLE INCOME COUNTRIESMOHMINISTRY OF HEALTHMOHFWMINISTRY OF HEALTH AND FAMILY WELFAREFP2030FAMILY PLANNING 2030RHSCREPRODUCTIVE HEALTH S

238、UPPLIES COALITIONRH VIZREPRODUCTIVE HEALTH SUPPLIES VISUALIZERUSAIDUNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENTUNFPAUNITED NATIONS POPULATION FUNDAPPENDICESACKNOWLEDGEMENTSThis report was produced as part of the landmark FP2020 Global Markets Visibility Project that the Clinton Health Access I

239、nitiative,Inc.(CHAI)launched in early 2014 in conjunction with the Reproductive Health Supplies Coalition(RHSC).The shipment data provided by suppliers is the foundation of this reports analyses and allows CHAI and RHSC to address information gaps and construct a comprehensive view of the reproducti

240、ve health commodities market.We would like to thank current participating suppliers:Bayer,Cipla,Corporate Channels,CR Zizhu,Cupid,Female Health Company,Incepta,Medicines360,Organon&Co.,Pfizer,Pregna,PT Tunggal,Renata*,Shanghai Dahua,SMB,Techno Drugs,and Viatris(Mylan),as well as our partner,Concept

241、Foundation,for their support in collecting and aggregating 2011-2017*data.We are also grateful to our colleagues from the Consensus Planning Group(CPG)*,John Snow Inc.(JSI),the United Nations Population Fund(UNFPA),the United States Agency for International Development(USAID),the Global Health Suppl

242、y Chain Program Procurement and Supply Management(GHSC-PSM),and FP2030 for their invaluable feedback during the development and refinement of various market analyses.*Renata is a new participating supplier in this years report.Refer to pages 19-20 for more information on Renata and other participati

243、ng suppliers.*CHAI began collecting data directly from suppliers in the former GEMS Caucus in 2018.*The Consensus Planning Group(CPG),established in 2020,collaborates at the global level to address family planning commodity stock imbalances while also planning to prevent those imbalances from occurring at all.Additional information available at:https:/www.rhsupplies.org/uploads/tx_rhscpublications/CPG_2020_FINAL.pdf